On 2025-05-15, Oncobiologics, Inc. (OTLK) announced earnings per share of $-0.40 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.55.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.42 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.55 | $-0.40 |
| 2025-02-14 | 2024-12-31 | $-0.85 | $-0.89 |
| 2024-12-27 | 2024-09-30 | $-0.83 | $-0.77 |
| 2024-08-14 | 2024-06-30 | $-1.06 | $-0.83 |
| 2024-05-15 | 2024-03-31 | $-0.88 | $-1.55 |
| 2024-02-14 | 2023-12-31 | $-1.00 | $-0.80 |
| 2023-12-22 | 2023-09-30 | $-1.00 | $-1.00 |
| 2023-08-14 | 2023-06-30 | $-0.80 | $-1.60 |
| 2023-05-15 | 2023-03-31 | $-1.20 | $-0.60 |
| 2023-02-14 | 2022-12-31 | $-0.80 | $-1.60 |
| 2022-08-10 | 2022-06-30 | $-1.60 | $-1.60 |
| 2022-05-13 | 2022-03-31 | $-1.40 | $-1.80 |
| 2022-02-14 | 2021-12-31 | $-1.40 | $-1.60 |
| 2021-12-22 | 2021-09-30 | $-1.40 | $-1.60 |
| 2021-08-13 | 2021-06-30 | $-1.60 | $-1.40 |
| 2021-05-14 | 2021-03-31 | $-2.40 | $-1.80 |
| 2021-02-16 | 2020-12-31 | -- | $-2.40 |
| 2020-08-14 | 2020-06-30 | $-1.40 | $-0.60 |
| 2020-05-15 | 2020-03-31 | $-2.00 | $-7.20 |
| 2020-02-14 | 2019-12-31 | -- | $-5.80 |
| 2019-12-19 | 2019-09-30 | $-6.60 | $-4.80 |
| 2019-08-14 | 2019-06-30 | $-7.40 | $-4.80 |
| 2019-05-15 | 2019-03-31 | -- | $-12.00 |
| 2019-02-14 | 2018-12-31 | -- | $-16.00 |
| 2018-08-14 | 2018-06-30 | -- | $-33.60 |
| 2018-05-15 | 2018-03-31 | -- | $-49.60 |
| 2018-02-14 | 2017-12-31 | -- | $-44.80 |
| 2017-08-14 | 2017-06-30 | -- | $-59.20 |
| 2017-05-15 | 2017-03-31 | $-128.00 | $-67.20 |
| 2017-02-14 | 2016-12-31 | -- | $-126.40 |
| 2016-08-15 | 2016-06-30 | $-60.80 | $-256.00 |
| 2016-06-27 | 2016-03-31 | $-65.60 | $-51.20 |